|Last Price$87.41||Day Change (%)0.13%|
|Open Price$86.94||Day Change ($)0.11|
|Day Range86.89–87.57||52-Week Range85.41–106.67|
As of Fri 10/21/2016 7:49:00 PM | USD
Ladies and gentlemen, thank you for standing by. Welcome to the CVS Caremark Q1 2014 Earnings Conference Call. During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question-and-answer session. As a reminder, this conference is being recorded Friday, ...
Business Watch -- WSJ -2-
Business Watch -- WSJ
Consolidated Tomoka Announces Acquisition of a CVS Ground Lease in Dallas, Texas for Approximately $14.9 Million
This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...
Pharmacy benefit managers aren't household names, but recent consolidation in the industry is proving out the power of scale for these firms, says Morningstar's Matt Coffina.
The wide-moat pharmacy benefit manager is still undervalued.
On Sunday, Caremark RX CMX announced that its board unanimously rejected Express Scripts' ESRX bid for the company and will continue to pursue the merger with CVS CVS . We are not changing our fair value estimates as a result of this announcement, since our estimates for all firms assume that CVS ...
This report includes candid statements and observations regarding investment strategies, individual securities, and economic and market conditions; however, there is no guarantee that these statements, opinions or forecasts will prove to be correct. Equity markets are volatile and an investor may ...
Investors concerned with Express Scripts' integration of Medco are overlooking the firm's long-term potential to benefit from an increased focus on health-care cost-cutting, says Morningstar StockInvestor editor Matt Coffina.